检索结果 - Masahiro Tsuda

Refine Results
  1. 1
    A Novel Membrane Glycoprotein, SHPS-1, That Binds the SH2-Domain-Containing Protein Tyrosine Phosphatase SHP-2 in Response to Mitogens and Cell Adhesion

    A Novel Membrane Glycoprotein, SHPS-1, That Binds the SH2-Domain-Containing Protein Tyrosine Phosphatase SHP-2 in Response to Mitogens and Cell Adhesion 由 Yohsuke Fujioka, Takashi Matozaki, Tetsuya Noguchi, Akihiro Iwamatsu, Takuji Yamao, Nobuaki Takahashi, Masahiro Tsuda, Toshiyuki Takada, Masato Kasuga

    出版 1996
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Tyrosine phosphorylation of p62Dok induced by cell adhesion and insulin: possible role in cell migration

    Tyrosine phosphorylation of p62Dok induced by cell adhesion and insulin: possible role in cell migration 由 Tetsuya Noguchi, Takashi Matozaki, Kenjiro Inagaki, Masahiro Tsuda, Kaoru Fukunaga, Yukari Kitamura, Tadahiro Kitamura, Kozui Shii, Yuji Yamanashi, Masato Kasuga

    出版 1999
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Roles of the Complex Formation of SHPS-1 with SHP-2 in Insulin-stimulated Mitogen-activated Protein Kinase Activation

    Roles of the Complex Formation of SHPS-1 with SHP-2 in Insulin-stimulated Mitogen-activated Protein Kinase Activation 由 Toshiyuki Takada, Takashi Matozaki, Hitoshi Takeda, Kaoru Fukunaga, Tetsuya Noguchi, Yohsuke Fujioka, Issay Okazaki, Masahiro Tsuda, Takuji Yamao, Fukashi Ochi, Masato Kasuga

    出版 1998
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Deletion of Angiotensin II Type 2 Receptor Exaggerated Atherosclerosis in Apolipoprotein E–Null Mice

    Deletion of Angiotensin II Type 2 Receptor Exaggerated Atherosclerosis in Apolipoprotein E–Null Mice 由 Masaru Iwai, Rui Chen, Zhen Li, Tetsuya Shiuchi, Jun Suzuki, Ayumi Ide, Masahiro Tsuda, Midori Okumura, Li‐Juan Min, Masaki Mogi, Masatsugu Horiuchi

    出版 2005
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Integrin-mediated Tyrosine Phosphorylation of SHPS-1 and Its Association with SHP-2

    Integrin-mediated Tyrosine Phosphorylation of SHPS-1 and Its Association with SHP-2 由 Masahiro Tsuda, Takashi Matozaki, Kaoru Fukunaga, Yohsuke Fujioka, Akira Imamoto, Tetsuya Noguchi, Toshiyuki Takada, Takuji Yamao, Hitoshi Takeda, Fukashi Ochi, Tadashi Yamamoto, Masato Kasuga

    出版 1998
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Fluvastatin Enhances the Inhibitory Effects of a Selective AT <sub>1</sub> Receptor Blocker, Valsartan, on Atherosclerosis

    Fluvastatin Enhances the Inhibitory Effects of a Selective AT <sub>1</sub> Receptor Blocker, Valsartan, on Atherosclerosis 由 Zhen Li, Masaru Iwai, Lan Wu, Hongwei Liu, Rui Chen, Toyohisa Jinno, Jun Suzuki, Masahiro Tsuda, Xinyu Gao, Midori Okumura, Taixing Cui, Masatsugu Horiuchi

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Inhibitory Effects of AT <sub>1</sub> Receptor Blocker, Olmesartan, and Estrogen on Atherosclerosis Via Anti-Oxidative Stress

    Inhibitory Effects of AT <sub>1</sub> Receptor Blocker, Olmesartan, and Estrogen on Atherosclerosis Via Anti-Oxidative Stress 由 Masahiro Tsuda, Masaru Iwai, Jian‐Mei Li, Huan-Sheng Li, Li‐Juan Min, Ayumi Ide, Midori Okumura, Jun Suzuki, Masaki Mogi, Hiromichi Suzuki, Masatsugu Horiuchi

    出版 2005
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)

    Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1) 由 Yukinori Kurokawa, Naotoshi Sugimoto, Hiroto Miwa, Masahiro Tsuda, Shigeaki Nishina, Hiroyuki Okuda, Hiroshi Imamura, Makio Gamoh, Daisuke Sakai, Toshio Shimokawa, Yoshito Komatsu, Yuichiro� Doki, Toshimasa Tsujinaka, Hiroshi Furukawa

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Randomized study of <scp>FOLFIRI</scp> plus either panitumumab or bevacizumab for wild‐type <scp>KRAS</scp> colorectal cancer‐<scp>WJOG</scp> 6210G

    Randomized study of <scp>FOLFIRI</scp> plus either panitumumab or bevacizumab for wild‐type <scp>KRAS</scp> colorectal cancer‐<scp>WJOG</scp> 6210G 由 Kohei Shitara, Kimio Yonesaka, Tadamichi Denda, Kentaro Yamazaki, Toshikazu Moriwaki, Masahiro Tsuda, Toshimi Takano, Hiroyuki Okuda, Tomohiro Nishina, Kazuko Sakai, Kazuto Nishio, Shoji Tokunaga, Takeharu Yamanaka, Narikazu Boku, Ichinosuke Hyodo, Kei Muro

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    A Novel Serum Metabolomics-Based Diagnostic Approach to Pancreatic Cancer

    A Novel Serum Metabolomics-Based Diagnostic Approach to Pancreatic Cancer 由 Takashi Kobayashi, Shin Nishiumi, Atsuki Ikeda, Tomoo Yoshie, Aya Sakai, Atsuki Matsubara, Yoshihiro Izumi, Hidetaka Tsumura, Masahiro Tsuda, Hogara Nishisaki, Nobuhide Hayashi, Seiji Kawano, Yutaka Fujiwara, Hironobu Minami, Tadaomi Takenawa, Takeshi Azuma, Masaru Yoshida

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)

    Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (AT... 由 Masanobu Takahashi, Ken Kato, Morihito Okada, Keisho Chìn, Shigenori Kadowaki, Yasuo Hamamoto, Yuichiro� Doki, Yutaro Kubota, Hisato Kawakami, Takashi Ogata, Hiroki Hara, Manabu Muto, Yuichiro Nakashima, Ryu Ishihara, Masahiro Tsuda, Satoru Motoyama, Mamoru Kodani, Yuko Kitagawa

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)

    Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroeso... 由 Narikazu Boku, Min‐Hee Ryu, Ken Kato, Hyun Cheol Chung, Keiko Minashi, K.-W. Lee, H. Cho, Won Ki Kang, Yoshito Komatsu, Masahiro Tsuda, Kensei Yamaguchi, Hiroki Hara, Soichi Fumita, Mizutomo Azuma, L.-T. Chen, Yoon‐Koo Kang

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial

    S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open... 由 Yasuhide Yamada, Tadamichi Denda, Makio Gamoh, Ichiro Iwanaga, Satoshi Yuki, Hideki Shimodaira, Masato Nakamura, Tatsuro Yamaguchi, Hisatsugu Ohori, K. Kobayashi, Masahiro Tsuda, Y. Kobayashi, Yuji Miyamoto, Masanori Kotake, K. Shimada, A. Sato, Satoshi Morita, Shin Takahashi, Yoshito Komatsu, Chikashi Ishioka

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1 data from the KEYNOTE-659 phase IIb study

    Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1... 由 Akihito Kawazoe, Kensei Yamaguchi, Hisateru Yasui, Yuji Negoro, Mizutomo Azuma, Kenji Amagai, Hiroki Hara, Hideo Baba, Masahiro Tsuda, Hisashi Hosaka, Hisato Kawakami, Takashi Oshima, Yasushi Omuro, Nozomu Machida, Taito Esaki, Kazuhiro Yoshida, Tomohiro Nishina, Yoshito Komatsu, Shi Rong Han, Shinichi Shiratori, Kohei Shitara

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer

    Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer 由 Yasuhide Yamada, Katsuhiko Higuchi, Kazuhiro Nishikawa, Marco Durante, Nozomu Fuse, Naotoshi Sugimoto, Tomohiro Nishina, Kenji Amagai, Keisho Chìn, Y. Niwa, Akihito Tsuji, Hiroshi Imamura, Masahiro Tsuda, Hirofumi Yasui, Hirofumi Fujii, Kensei Yamaguchi, Hisateru Yasui, Shuichi Hironaka, Keiji Shimada, Hiroto Miwa, Chieko Hamada, Ichinosuke Hyodo

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer

    Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer 由 Hideaki Bando, Yasuhide Yamada, Satoshi Tanabe, Kazuhiro Nishikawa, Masahiro Gotoh, Naotoshi Sugimoto, Tomohiro Nishina, Kenji Amagai, Keisho Chìn, Yasumasa Niwa, Akihito Tsuji, Hiroshi Imamura, Masahiro Tsuda, Hirofumi Yasui, Hirofumi Fujii, Kensei Yamaguchi, Hisateru Yasui, Shuichi Hironaka, Ken Shimada, Hiroto Miwa, Chikuma Hamada, Ichinosuke Hyodo

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Robust circulating microRNA signature for the diagnosis and early detection of pancreatobiliary cancer

    Robust circulating microRNA signature for the diagnosis and early detection of pancreatobiliary cancer 由 Shuichi Mitsunaga, Masafumi Ikeda, Makoto Ueno, Satoshi Kobayshi, Masahiro Tsuda, Ikuya Miki, Takamichi Kuwahara, Kazuo Hara, Yukiko Takayama, Yutaro Matsunaga, Keiji Hanada, Akinori Shimizu, Hitoshi Yoshida, Tomohiro Nomoto, Kenji Takahashi, Hidetaka Iwamoto, Hideaki Iwama, Etsuro Hatano, Kohei Nakata, Masafumi Nakamura, Hiroko Sudo, Satoko Takizawa, Atsushi Ochiai

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial

    A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-... 由 Masatoshi Kudo, Kazuomi Ueshima, Issei Saeki, Toru Ishikawa, Yoshitaka Inaba, Naoki Morimoto, Hiroshi Aikata, Nobukazu Tanabe, Yoshiyuki Wada, Yasuteru Kondo, Masahiro Tsuda, Kazuhiko Nakao, Takanori Ito, Tetsuya Hosaka, Yusuke Kawamura, Teiji Kuzuya, Shunsuke Nojiri, Chikara Ogawa, Hironori Koga, Keisuke Hino, Masafumi Ikeda, Michihisa Moriguchi, Takashi Hisai, Kenichi Yoshimura, Junji Furuse, Yasuaki Arai

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer

    Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer 由 S. Ohkawa, Takuji Okusaka, Hiroyuki Isayama, Akira Fukutomi, Kensei Yamaguchi, Masafumi Ikeda, A Funakoshi, Michitaka Nagase, Yasuo Hamamoto, Shoji Nakamori, Y. Tsuchiya, Hideo Baba, Hiroshi Ishii, Yasushi Omuro, Masayuki Sho, Shigemi Matsumoto, N. Yamada, Hiroaki Yanagimoto, Michiaki Unno, Yasushi Ichikawa, Shin Takahashi, G Watanabe, Go Wakabayashi, Naoto Egawa, Masahiro Tsuda, Ryo Hosotani, Chieko Hamada, Ichinosuke Hyodo

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer

    Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivol... 由 Taroh Satoh, Yoon‐Koo Kang, Yee Chao, Min‐Hee Ryu, Ken Kato, Hyun Cheol Chung, Jen‐Shi Chen, Kei Muro, Won Ki Kang, Kun‐Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun‐Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chìn, Do‐Youn Oh, Keiko Minashi, Y. Choi, Masahiro Tsuda, M Tanimoto, Li‐Tzong Chen, Narikazu Boku

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: